Financing ·
CollPlant raises $3.7M in private placement at $3.74 per share to fund LightSolver R&D
CLGNCollPlant Biotechnologies Ltd
CollPlant Biotechnologies announced a $3.7 million private placement of 989,301 ordinary shares and warrants exercisable for up to 1,483,952 additional shares. The securities were sold at $3.74 per share to existing investors, with closing expected around October 14, 2026. Proceeds will primarily accelerate research and development for subsidiary LightSolver's laser-based supercomputing architecture and support general corporate purposes. CollPlant operates in deep-tech photonic computing and advanced biotechnology.